| Whitney Browning, MD | |
|
3601 Tvc, Nashville, TN 37232-0001 | |
| (615) 322-3000 | |
| Not Available |
| Full Name | Whitney Browning |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 3601 Tvc, Nashville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780731588 | NPI | - | NPPES |
| 1514658 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD43832 (Tennessee) | Secondary |
| 208000000X | Pediatrics | MD43832 (Tennessee) | Primary |
| Entity Name | Vanderbilt University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
Eli Lilly and Company today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.
Patients who had complex gynecologic surgery managed by an enhanced recovery pathway resulted in decreased narcotic use, earlier discharge, stable readmission rates, excellent patient satisfaction and cost savings, according to a Mayo Clinic study.
A network of proteins underlying the plasma membrane keeps epithelial cells in shape and maintains their orderly hexagonal packing in the mouse lens, say Nowak et al. The study will appear in the September 21, 2009 issue of the Journal of Cell Biology (online September 14).
Burzynski Research Institute, Inc. announced today that the U.S. Food and Drug Administration has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 months of age with a diffuse intrinsic brainstem glioma (DIPG).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Whitney Browning, MD 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: (615) 322-3000 | Whitney Browning, MD 3601 Tvc, Nashville, TN 37232-0001 Ph: (615) 322-3000 |
News Archive
Eli Lilly and Company today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.
After nearly two decades building her company into the industry leader for third-party review of dental insurance claims, Dianne Rose, D.D.S., and principal of P&R Dental Strategies, Inc., was frustrated. In spite of many advances over the years in both dental x-ray technologies and the average quality of images supplied for review of dental claims, there was no consistency and, all-too-often, regardless of how up-to-date the x-ray equipment being used may have been, the images supplied were blurred and nearly useless for making accurate diagnostic determinations.
Patients who had complex gynecologic surgery managed by an enhanced recovery pathway resulted in decreased narcotic use, earlier discharge, stable readmission rates, excellent patient satisfaction and cost savings, according to a Mayo Clinic study.
A network of proteins underlying the plasma membrane keeps epithelial cells in shape and maintains their orderly hexagonal packing in the mouse lens, say Nowak et al. The study will appear in the September 21, 2009 issue of the Journal of Cell Biology (online September 14).
Burzynski Research Institute, Inc. announced today that the U.S. Food and Drug Administration has given the company permission to conduct an open-label study of Antineoplastons A10 and AS2-1 in patients > 3 months of age with a diffuse intrinsic brainstem glioma (DIPG).
› Verified 6 days ago
George Anne Raines, APRN Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Jenny Kingsley, Pediatrics Medicare: Medicare Enrolled Practice Location: 2200 Childrens Way, Suite 2404, Nashville, TN 37232 Phone: 615-936-1000 | |
Dr. Sheung Man Alexander Sin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Dr. Zenarosa C Salcedo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 339 White Bridge Pike, Nashville, TN 37209 Phone: 615-356-6877 Fax: 615-356-8270 | |
Dr. Deborah P Jones, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 3601 Tvc, Nashville, TN 37232 Phone: 615-322-3000 | |
Joseph Gigante, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Dr. Michael Warren, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2200 Childrens Way, Dot 8232, Nashville, TN 37232 Phone: 615-936-2425 Fax: 615-343-4655 |